Diabetic Retinopathy Drug Market Projected to Register a CAGR of +14% by 2023, According to Top Research Firm
Diabetic retinopathy (DR) is an eye disease associated with diabetic patients. The disease occurs when there is damage to the retina due to diabetes. Without timely treatment, the disease may lead to bleeding in the eyes, cloudy vision, and may even destroy the retina. DR is amongst the common cause of loss of vision in the diabetic population; eventually leading to blindness.
View full press release